RHC 3659: a new orally active angiotensin converting enzyme inhibitor in normal volunteers.

M Burnier, GA Turini, HR Brunner… - British Journal of …, 1981 - Wiley Online Library
1 The new converting enzyme inhibitor RHC 3659 was tested in 15 male volunteers. The
study consisted of two parts: first, the ability of a single oral dose (5, 10, 20, 40 or 80 mg) to …

[引用][C] RHC 3659; NEW ORALLY ACTIVE ANGIOTENSIN CONVERTING ENZYME INHIBITOR IN NORMAL VOLUNTEERS

M BURNIER, T GA, B HR, M PORCHET, D KRUITHOF… - 1981 - pascal-francis.inist.fr
Keyword (fr) ANGIOTENSIN CONVERTING ENZYME INHIBITEUR ENZYME HOMME VOIE
ORALE DOSE UNIQUE PRESSION ARTERIELLE RYTHME CARDIAQUE RENIN PLASMA …

RHC 3659: a new orally active angiotensin converting enzyme inhibitor in normal volunteers

M Burnier, GA Turini, HR Brunner… - British journal of …, 1981 - pubmed.ncbi.nlm.nih.gov
1 The new converting enzyme inhibitor RHC 3659 was tested in 15 male volunteers. The
study consisted of two parts: first, the ability of a single oral dose (5, 10, 20, 40 or 80 mg) to …

RHC 3659: a new orally active angiotensin converting enzyme inhibitor in normal volunteers.

M Burnier, GA Turini, HR Brunner… - British Journal of …, 1981 - europepmc.org
Abstract 1 The new converting enzyme inhibitor RHC 3659 was tested in 15 male
volunteers. The study consisted of two parts: first, the ability of a single oral dose (5, 10, 20 …

RHC 3659: a new orally active angiotensin converting enzyme inhibitor in normal volunteers.

M Burnier, GA Turini, HR Brunner… - British Journal of …, 1981 - ncbi.nlm.nih.gov
Abstract 1 The new converting enzyme inhibitor RHC 3659 was tested in 15 male
volunteers. The study consisted of two parts: first, the ability of a single oral dose (5, 10, 20 …